GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹11,583 Cr | ₹12,305 Cr | ₹10,944 Cr | ₹10,641 Cr | ₹9,865 Cr |
What is the latest Revenue of GLENMARK PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2024 | ₹11,583 Cr |
Mar2023 | ₹12,305 Cr |
Mar2022 | ₹10,944 Cr |
Mar2021 | ₹10,641 Cr |
Mar2020 | ₹9,865 Cr |
How is Revenue of GLENMARK PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹11,583 Cr | -5.86 | |
Mar2023 | ₹12,305 Cr | 12.44 | |
Mar2022 | ₹10,944 Cr | 2.85 | |
Mar2021 | ₹10,641 Cr | 7.86 | |
Mar2020 | ₹9,865 Cr | - |
Compare Revenue of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹62,734.5 Cr | 0.2% | 35.6% | 57.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | 0.2% |
35.6% |
57.9% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses